» Articles » PMID: 35295418

Role of Connexin 43 in an Inflammatory Model for TMJ Hyperalgesia

Overview
Date 2022 Mar 17
PMID 35295418
Authors
Affiliations
Soon will be listed here.
Abstract

Temporomandibular joint disorders (TMD) consist of a heterogeneous group of conditions that present with pain in the temporomandibular joint (TMJ) region and muscles of mastication. This project assessed the role of connexin 43 (Cx43), a gap junction protein, in the trigeminal ganglion (TG) in an animal model for persistent inflammatory TMJ hyperalgesia. Experiments were performed in male and female rats to determine if sex differences influence the expression and/or function of Cx43 in persistent TMJ hyperalgesia. Intra-TMJ injection of Complete Freund's Adjuvant (CFA) caused a significant increase in Cx43 expression in the TG at 4 days and 10 days post-injection in ovariectomized (OvX) female rats and OvX females treated with estradiol (OvXE), while TG samples in males revealed only marginal increases. Intra-TG injection of interference RNA for Cx43 (siRNA Cx43) 3 days prior to recording, markedly reduced TMJ-evoked masseter muscle electromyographic (MMemg) activity in all CFA-inflamed rats, while activity in sham animals was not affected. Western blot analysis revealed that at 3 days after intra-TG injection of siRNA Cx43 protein levels for Cx43 were significantly reduced in TG samples of all CFA-inflamed rats. Intra-TG injection of the mimetic peptide GAP19, which inhibits Cx43 hemichannel formation, greatly reduced TMJ-evoked MMemg activity in all CFA-inflamed groups, while activity in sham groups was not affected. These results revealed that TMJ inflammation caused a persistent increase in Cx43 protein in the TG in a sex-dependent manner. However, intra-TG blockade of Cx43 by siRNA or by GAP19 significantly reduced TMJ-evoked MMemg activity in both males and females following TMJ inflammation. These results indicated that Cx43 was necessary for enhanced jaw muscle activity after TMJ inflammation in males and females, a result that could not be predicted on the basis of TG expression of Cx43 alone.

Citing Articles

Mechanisms for Orofacial Pain: Roles of Immunomodulation, Metabolic Reprogramming, Oxidative Stress and Epigenetic Regulation.

Khan S, Tao F Biomedicines. 2025; 13(2).

PMID: 40002847 PMC: 11853523. DOI: 10.3390/biomedicines13020434.


Estrogen Status and Trigeminal Ganglion Responses to Jaw Movement.

Zhang X, Rahman M, Bereiter D J Dent Res. 2022; 101(9):1075-1081.

PMID: 35259995 PMC: 9305844. DOI: 10.1177/00220345221077951.

References
1.
Zhang P, Bi R, Gan Y . Glial interleukin-1β upregulates neuronal sodium channel 1.7 in trigeminal ganglion contributing to temporomandibular joint inflammatory hypernociception in rats. J Neuroinflammation. 2018; 15(1):117. PMC: 5910598. DOI: 10.1186/s12974-018-1154-0. View

2.
Ambalavanar R, Moritani M, Haines A, Hilton T, Dessem D . Chemical phenotypes of muscle and cutaneous afferent neurons in the rat trigeminal ganglion. J Comp Neurol. 2003; 460(2):167-79. DOI: 10.1002/cne.10655. View

3.
Isselee H, De Laat A, De Mot B, Lysens R . Pressure-pain threshold variation in temporomandibular disorder myalgia over the course of the menstrual cycle. J Orofac Pain. 2002; 16(2):105-17. View

4.
Chen C, Lin C, Lee T . 17beta-Estradiol decreases vulnerability to ventricular arrhythmias by preserving connexin43 protein in infarcted rats. Eur J Pharmacol. 2009; 629(1-3):73-81. DOI: 10.1016/j.ejphar.2009.11.050. View

5.
Mogil J . Animal models of pain: progress and challenges. Nat Rev Neurosci. 2009; 10(4):283-94. DOI: 10.1038/nrn2606. View